BioSpace News Archive

Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, today announced that company management will attend in the 9th Annual SVB Leerink Global Healthcare Conference at the Lotte New York Palace in New York, New York

Mersana Therapeutics, Inc. (NASDAQ:MRSN), today announced that it will host a conference call and webcast on Friday, February 28, 2020 at 8:00 a.m. ET to report financial results for the fourth quarter and year ended December 31, 2019 and provide business updates.

MINNEAPOLIS, Feb. 21, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a data and artificial intelligence (“AI”) driven discovery services company that provides predictive models of tumor drug response to improve clinical outcomes for patients, today announced that its Board of Directors has unanimously appointed Dan Handley, M.S., Ph.D., to the Board. Dr. Handley serves as a Professor and the Director of the Clinical and Translationa

IRVINE, Calif. , Feb. 21, 2020 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced a new goal for its philanthropic initiative, Every Heartbeat Matters (EHM): to improve the lives of 2.5 million additional underserved structural heart and crit

Feb. 21, 2020 13:30 UTC Frequency Therapeutics to Present at the 40 th Annual Cowen Healthcare Conference WOBURN, Mass.--( BUSINESS WIRE )-- Frequency Therapeutics, Inc. (Nasdaq: FREQ), a clinical-stage biotechnology company focused on harnessing the body’s innate biology to repair or reverse damage caused by a broad range of degenerative diseases, today announced that Chief Executive Officer David L. Lucchino will present a company overview at the Cowen 40 th Annual Healthcare C

In a report released this morning, the Personalized Medicine Coalition (PMC) explains how 12 personalized treatments and seven diagnostics the U.S. Food and Drug Administration (FDA) approved or cleared in 2019 will improve patient care and make the health system more efficient by addressing root causes of rare diseases, expanding treatment options for cancer patients, and targeting therapies to responder populations.

Australian health and wellness company, Lifestart Naturopathics brings its one-of-a-kind herbal supplement, Fem21, to the Efficient Collaborative Retail Marketing (ECRM) Conference this March, in St. Louis, Missouri.

SAN DIEGO, Feb. 21, 2020 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE, “Sorrento”), announced today that it will present at LEERINK Partners 9th Annual Global Healthcare Conference (Lotte New York Palace Hotel, New York) on Thursday Feb 27 at 11:00-11:25 AM (Presentation Room Adams). The webcast will be available through http://wsw.com/webcast/svbleerink34/srne during the conference and for the following 96 days. The presentation will also be accessible on the company

WATERTOWN, Mass., Feb. 21, 2020 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a biopharmaceutical company committed to developing and commercializing innovative ophthalmic products today announced the pricing of an underwritten public offering of 15,000,000 shares of its common stock at a public offering price of $1.45 per share. The gross proceeds of the offering to the Company are expected to be approximately $21,750,000, before deducting the underwriting discounts and c

Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate for treating excessive daytime sleepiness and cataplexy in patients with narcolepsy, announced today that it entered into a definitive agreement